An observational study in STEMI, sponsored by Beijing Friendship Hospital. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2020-06-11.
Sponsored by Beijing Friendship Hospital · Observational
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. The patients' prognosis is poor because the epidemic situation runs on medical resources, delays the diagnosis and treatment of other diseases such as cardiovascular diseases, and the patients' willingness to see a doctor is reduced. In particular, the delay in the treatment of STEMI, which needs PCI treatment, will cause more damage to the patients. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic. In this study, STEMI patients who experienced emergency PCI treatment after the covid-19 outbreak in 2020 were included, and compared with the data of the same period in 2019,we will analyze the pre hospital treatment time, vascular opening time,and the major cardiovascular adverse events, which provide effective suggestions and strategies for emergency and severe treatment.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's planned enrollment of 200 is below the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →Beijing Friendship Hospital is the lead sponsor of 216 studies on the registry; 95 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention
Exclusion Criteria:
Patients with myocardial infarction from January 24, 2019 to June 24, 2019
Patients with myocardial infarction from January 24, 2020 to June 24, 2020
MACE (major adverse cardiovascular events)
cardiovascular death, re-infarction, malignant arrhythmia,heart failure, revascularization, and stroke
Time frame: 1 year
all-cause death
death caused by all reason
Time frame: 1 year
This study is status unknown, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beijing Friendship Hospital